Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,484 across all filing types
Latest filing 2022-06-14 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 13 June 2022.
Director's Dealing Classification · 100% confidence The document is explicitly titled 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It details transactions (Buy operations) executed by an entity ('Telso' AD) related to an individual ('Vesela Stoeva') concerning shares in the Company. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The appropriate code is DIRS.
2022-06-14 English
Treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a 'Current report' dated June 14, 2022, specifically titled 'Treasury shares'. The content details a transaction where Sopharma AD bought back 224,000 of its own shares, specifying the number, percentage of share capital, total value, and average price. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing type code for this activity is POS.
2022-06-14 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 10 June 2022.
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details specific transactions (Buy operations) executed by an entity related to a director/insider ("Vesela Stoeva") concerning shares in the Company. This directly matches the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is short, but its content is the transaction report itself, not an announcement of a report.
2022-06-13 English
Notification under Art. 111 para. 6 of LPOS for repurchase of shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Current report №30/ 2022' and explicitly states that the company ('Sopharma' AD) 'notifies that the company intends to buy its own shares' (repurchase). It details the number of shares, the price, and the date for this action. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase).
2022-06-10 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 9 June 2022.
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions (Buy operations) executed by an entity ("Telso" AD) related to shares in the Company, involving an individual ("Vesela Stoeva"). This directly corresponds to the definition of Director's Dealing (insider trades by directors and executives). Therefore, the correct classification code is DIRS.
2022-06-10 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 7 June 2022.
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions (Buy operations) executed by an individual related to the company's shares. This directly corresponds to the definition of Director's Dealing (insider trades by directors and executives). The filing type code for this is DIRS.
2022-06-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.